Stokes Family Office, LLC Bristol Myers Squibb CO Transaction History

Stokes Family Office, LLC

  • $854 Million
  • Q1 2025

A detailed history of Stokes Family Office, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stokes Family Office, LLC holds 36,402 shares of BMY stock, worth $1.71 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
36,402
Previous 37,190 2.12%
Holding current value
$1.71 Million
Previous $2.1 Million 5.56%
% of portfolio
0.26%
Previous 0.23%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$53.9 - $63.11 $42,473 - $49,730
-788 Reduced 2.12%
36,402 $2.22 Million
Q4 2024

Feb 10, 2025
SELL
$51.92 - $59.94 $94,130 - $108,671
-1,813 Reduced 4.65%
37,190 $2.1 Million
Q3 2024

Nov 12, 2024
SELL
$39.66 - $51.75 $74,005 - $96,565
-1,866 Reduced 4.57%
39,003 $2.02 Million
Q2 2024

Jul 05, 2024
SELL
$40.25 - $52.99 $14,329 - $18,864
-356 Reduced 0.86%
40,869 $1.7 Million
Q1 2024

May 06, 2024
BUY
$47.98 - $54.4 $37,472 - $42,486
781 Added 1.93%
41,225 $2.24 Million
Q4 2023

Feb 06, 2024
SELL
$48.48 - $57.85 $67,435 - $80,469
-1,391 Reduced 3.32%
40,444 $2.08 Million
Q3 2023

Nov 13, 2023
BUY
$57.89 - $64.73 $14,356 - $16,053
248 Added 0.6%
41,835 $2.43 Million
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $18,475 - $20,514
290 Added 0.7%
41,587 $2.66 Million
Q1 2023

May 08, 2023
SELL
$65.71 - $74.53 $21,092 - $23,924
-321 Reduced 0.77%
41,297 $2.86 Million
Q4 2022

Feb 14, 2023
BUY
$68.48 - $81.09 $51,291 - $60,736
749 Added 1.83%
41,618 $2.99 Million
Q3 2022

Nov 10, 2022
BUY
$0.13 - $76.84 $85 - $50,560
658 Added 1.64%
40,869 $2.91 Million
Q2 2022

Aug 05, 2022
BUY
$72.62 - $79.98 $50,035 - $55,106
689 Added 1.74%
40,211 $3.1 Million
Q1 2022

May 16, 2022
BUY
$61.48 - $73.72 $10,943 - $13,122
178 Added 0.45%
39,522 $2.89 Million
Q4 2021

Feb 15, 2022
SELL
$53.63 - $62.52 $47,248 - $55,080
-881 Reduced 2.19%
39,344 $2.45 Million
Q3 2021

Nov 15, 2021
SELL
$59.17 - $69.31 $32,602 - $38,189
-551 Reduced 1.35%
40,225 $2.38 Million
Q2 2021

Aug 12, 2021
BUY
$61.91 - $67.42 $47,113 - $51,306
761 Added 1.9%
40,776 $2.73 Million
Q1 2021

May 13, 2021
BUY
$59.34 - $66.74 $67,766 - $76,217
1,142 Added 2.94%
40,015 $2.53 Million
Q4 2020

Feb 10, 2021
BUY
$57.74 - $65.43 $22,865 - $25,910
396 Added 1.03%
38,873 $2.41 Million
Q3 2020

Nov 12, 2020
BUY
$57.43 - $63.64 $47,954 - $53,139
835 Added 2.22%
38,477 $2.32 Million
Q2 2020

Aug 11, 2020
BUY
$54.82 - $64.09 $40,950 - $47,875
747 Added 2.02%
37,642 $2.21 Million
Q1 2020

May 12, 2020
BUY
$46.4 - $67.43 $5,104 - $7,417
110 Added 0.3%
36,895 $2.06 Million
Q4 2019

Feb 10, 2020
BUY
$49.21 - $64.19 $1.81 Million - $2.36 Million
36,785 New
36,785 $2.36 Million

Others Institutions Holding BMY

# of Institutions
2,806
Shares Held
1.59B
Call Options Held
25.9M
Put Options Held
23.9M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.6B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Stokes Family Office, LLC Portfolio

Follow Stokes Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Family Office, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email